Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Brickell Biotech Q2 EPS $(0.01) Up From $(0.16) YoY, Sales $4.32M Beat $3.13M Estimate

Author: Benzinga Newsdesk | August 11, 2022 05:23pm
Brickell Biotech (NASDAQ:BBI) reported quarterly losses of $(0.01) per share. This is a 93.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $4.32 million which beat the analyst consensus estimate of $3.13 million by 37.86 percent. This is a 2.76K percent increase over sales of $151.00 thousand the same period last year.

Posted In: BBI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist